Rapid Micro Biosystems Q2 revenue beats; reaffirms 2026 revenue forecast

Rapid Micro Biosystems

07/08/2026 12:10

Overview
U.S. life sciences automation provider's Q2 revenue grew 11% yr/yr, beating analyst expectations
Company reported record Q2 gross margin of 15%, up 11 percentage points yr/yr
Company reaffirmed full-year 2026 revenue and gross margin guidance

Outlook
Rapid Micro Biosystems reaffirms 2026 total revenue guidance of $37.0 mln to $41.0 mln
Company reaffirms 2026 gross margin guidance of approximately 20%, with H2 margins in mid-20% range
Company raises 2026 system validation guidance to at least 27, up from 25 previously

Result Drivers
RECURRING AND CONSUMABLE SALES - Co said Q2 recurring revenue rose 14% yr/yr and consumable revenue grew over 20%, supporting overall revenue growth
MARGIN INITIATIVES - Co attributed record 15% Q2 gross margin to progress on margin expansion initiatives
SYSTEM PLACEMENTS AND VALIDATIONS - Four new Growth Direct systems placed and nine validations completed in Q2, with co citing strong customer engagement and enterprise deployment momentum

Company press release: ID:nGNX1Mrtr3

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$8.1 mln
$7.88 mln (4 Analysts)
Q2 Loss Per Share
 
$0.27
 
Q2 Net Loss
Miss
$12.90 mln
$11.70 mln (2 Analysts)
Q2 Operating Expenses
 
$13.50 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Rapid Micro Biosystems, Inc. is $7.00, about 236.5% above its August 6 closing price of $2.08

Reuters Recommended Reads
Aug 5 - Standard BioTools Q2 revenue falls on consumables weakness
Aug 4 - Waters lifts annual forecasts on strong lab-equipment and diagnostics demand
Aug 5 - Alpha Teknova Q2 revenue beats estimates, raises revenue 2026 outlook

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)